Literature DB >> 10069948

Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection.

O Herchenröder1, D Moosmayer, M Bock, T Pietschmann, A Rethwilm, P D Bieniasz, M O McClure, R Weis, J Schneider.   

Abstract

The interaction of simian foamy viruses (FVs) with their putative cellular receptor(s) was studied with two types of recombinant envelope protein (Env). Transient expression of full-length Env in BHK-21 cells induced syncytia formation. However, selected stable transfectants fused with naive cells but not with each other. A soluble fusion protein of the Env surface domain with the Fc fragment of a human IgG1 heavy chain (EnvSU-Ig) was produced in the baculovirus expression system, purified to homogeneity, and used for binding and competition analyses. EnvSU-Ig but not unrelated Ig fusion proteins bound to cells specifically. Neutralizing serum blocked binding of EnvSU-Ig and, vice versa, serum-mediated neutralization was abrogated by the chimeric protein. Concomitant reduction of EnvSU-Ig binding and FV susceptibility was seen in Env-expressing target cells. Although EnvSU-Ig did not inhibit FV infection, very likely due to its displacement by multivalent virus-cell interactions, this divalent ligand should help to characterize functionally and to identify the ubiquitous FV receptor. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069948     DOI: 10.1006/viro.1998.9570

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.

Authors:  Anja Duda; Daniel Lüftenegger; Thomas Pietschmann; Dirk Lindemann
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells.

Authors:  C D Meiering; K E Comstock; M L Linial
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Cocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa.

Authors:  Léa Richard; Réjane Rua; Edouard Betsem; Augustin Mouinga-Ondémé; Mirdad Kazanji; Eric Leroy; Richard Njouom; Florence Buseyne; Philippe V Afonso; Antoine Gessain
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

5.  Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.

Authors:  James M Binley; Stacie Ngo-Abdalla; Penny Moore; Michael Bobardt; Udayan Chatterji; Philippe Gallay; Dennis R Burton; Ian A Wilson; John H Elder; Aymeric de Parseval
Journal:  Retrovirology       Date:  2006-07-03       Impact factor: 4.602

6.  Modular nature of simian foamy virus genomes and their evolutionary history.

Authors:  Pakorn Aiewsakun; Léa Richard; Antoine Gessain; Augustin Mouinga-Ondémé; Philippe Vicente Afonso; Aris Katzourakis
Journal:  Virus Evol       Date:  2019-10-16

Review 7.  Retroviral superinfection resistance.

Authors:  Micha Nethe; Ben Berkhout; Antoinette C van der Kuyl
Journal:  Retrovirology       Date:  2005-08-18       Impact factor: 4.602

Review 8.  Early events in foamy virus-host interaction and intracellular trafficking.

Authors:  Ursula Berka; Martin Volker Hamann; Dirk Lindemann
Journal:  Viruses       Date:  2013-04-08       Impact factor: 5.048

9.  Discovery of prosimian and afrotherian foamy viruses and potential cross species transmissions amidst stable and ancient mammalian co-evolution.

Authors:  Aris Katzourakis; Pakorn Aiewsakun; Hongwei Jia; Nathan D Wolfe; Matthew LeBreton; Anne D Yoder; William M Switzer
Journal:  Retrovirology       Date:  2014-08-04       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.